Range
1.57 - 1.63
Vol / Avg.
1.2M/1.1M
Div / Yield
-
52 Wk
1.44 - 7.89
Mkt Cap
34.6M
Payout Ratio
-
Open
1.59
P/E
-
EPS
-0.32
Shares
21.4M
Outstanding
21.4M
Total Float
-
load more
Sector: Health Care.Industry: Biotechnology
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-13
REV
Q2 2021Est.ActualSurprise
EPS-0.320
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SONNSonnet BioTherapeutics2.53%34.6M

Sonnet BioTherapeutics Frequently Asked Questions

Q

How do I buy Sonnet BioTherapeutics (SONN) stock?

A

You can purchase shares of Sonnet BioTherapeutics (NASDAQ: SONN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Sonnet BioTherapeutics's (SONN) competitors?

Q

What is the target price for Sonnet BioTherapeutics (SONN) stock?

A

The latest price target for Sonnet BioTherapeutics (NASDAQ: SONN) was reported by Chardan Capital on September 4, 2020. The analyst firm set a price target for 8.00 expecting SONN to rise to within 12 months (a possible 393.83% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Sonnet BioTherapeutics (SONN)?

A

The stock price for Sonnet BioTherapeutics (NASDAQ: SONN) is $1.62 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Sonnet BioTherapeutics (SONN) pay a dividend?

A

There are no upcoming dividends for Sonnet BioTherapeutics.

Q

When is Sonnet BioTherapeutics (NASDAQ:SONN) reporting earnings?

A
Sonnet BioTherapeutics’s Q3 earnings are confirmed for after-market on August 13, 2021.
Q

Is Sonnet BioTherapeutics (SONN) going to split?

A

There is no upcoming split for Sonnet BioTherapeutics.

Q

What sector and industry does Sonnet BioTherapeutics (SONN) operate in?

A

Sonnet BioTherapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.